drugset / Trial / NCT04627129

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

NCT04627129

Phase 1 Completed 18 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the effect of Itraconazole on pharmacokinetics of healthy Chinese adult subjects after oral administration of SHR2554 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR2554 orally in healthy subjects.

Timeline

Start
2020-06-01
Primary completion
2020-10-01
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral
Subject SHR2554 Small molecule 50 mg Oral

Indications

No indication recorded.